Old Web
English
Sign In
Acemap
>
authorDetail
>
Jeffery A. Nieves
Jeffery A. Nieves
Pathology
Medicine
Cancer
Performance status
Tumor marker
3
Papers
7
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effect of exogenous interferon-gamma (IFN-gamma) on peripheral blood immune markers as part of a phase I clinical trial of combined IFN-gamma with nivolumab (Nivo) in patients (pts) with select solid tumors.
2018
Journal of Clinical Oncology
Matthew Zibelman
Alexander W. MacFarlane
R. Katherine Alpaugh
Essel Dulaimi
Kim Costello
John ONeill
Hossein Borghaei
Crystal S. Denlinger
Daniel M. Geynisman
Efrat Dotan
Angela Jain
Lainie P. Martin
Elias Obeid
Jeffery A. Nieves
David Crouteau
Amy Y. Grahn
Kerry S. Campbell
Elizabeth R. Plimack
Show All
Source
Cite
Save
Citations (2)
A retrospective analysis assessing effects of cytotoxic versus cytostatic agents on body mass, nutritional parameters, and performance status in patients with exocrine pancreas cancer enrolled in phase I and II trials.
2015
Journal of Clinical Oncology
John Philip Schwerkoske
Erkut Borazanci
Katy Schroeder
Lei Zhang
Gayle S. Jameson
Joyce Rosemarie Schaffer
Jeffery A. Nieves
Daniel D. Von Hoff
Show All
Source
Cite
Save
Citations (0)
The complete phase Ib clinical trial: A method to accelerate new agent development
2007
Journal of Clinical Oncology
D. D. Von Hoff
Jeffery A. Nieves
Linda Vocila
Steve Weitman
Esteban Cvitkovic
Show All
Source
Cite
Save
Citations (5)
1